Company & Sponsor Intelligence

University of Toronto

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting2

Completed2

Countries1

Therapeutic footprint

adhddepressionparkinsons

Indexed studies

NCT06638411Nocebo Education to Reduce the Potential Unintended Harms of Mental Health Awareness
adhd · CanadaNA

NCT05402163CANadian Adaptive DBS TriAl
parkinsons · CanadaNA

NCT05521360Autonomic Modulation Training for Police Exposed to Post-Traumatic Stress Injuries
depression · CanadaNA

NCT06127771Effects of Unblocking the Full Potential of Percept PC IPG
parkinsons · CanadaNA

NCT01657721Working Memory Training in ADHD (The Engage Study)
adhd · CanadaPHASE1

NCT06436313DBS Virtual Learning Experience
parkinsons · CanadaNA

NCT02347059L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
parkinsons · CanadaPHASE2

NCT04953637Physiotherapy and Deep Brain Stimulation in Parkinson's Disease
parkinsons · CanadaNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →